Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
ANIP ANI Pharmaceuticals
- 70.750
- +0.930+1.33%
Close Apr 28 16:00 ET
- 70.750
- 0.0000.00%
Post 16:32 ET
1.54BMarket Cap-68.03P/E (TTM)
71.850High68.901Low1.09MVolume70.000Open69.820Pre Close76.53MTurnover6.49%Turnover RatioLossP/E (Static)21.76MShares71.85052wk High3.81P/B1.19BFloat Cap52.50052wk Low--Dividend TTM16.77MShs Float392.040Historical High--Div YieldTTM4.22%Amplitude4.800Historical Low70.279Avg Price1Lot Size
ANI Pharmaceuticals Key Stats
EPS
According to the latest financial report of ANI Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.55. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about ANI Pharmaceuticals's free cash flow? The latest report shows it as 13.38M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ANI Pharmaceuticals shows that the company's current ratio is 2.72, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ANI Pharmaceuticals, the quick ratio is 1.93, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of ANI Pharmaceuticals? The latest ROE figure is -2.64%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ANI Pharmaceuticals, the total asset return on investment (ROA) is -0.83%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ANI Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 57.87%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ANI Pharmaceuticals, the net profit margin is -5.39%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
